Corinna Zygourakis, MD-Stanford Medicine Children's Health

Dr. Morrell is a Clinical Professor of Neurology at Stanford University since July 2004. Before joining NeuroPace, she was the Caitlin Tynan Doyle Professor of Clinical Neurology at Columbia University and Director of the Columbia Comprehensive Epilepsy Center at New York Presbyterian Hospital in New York City. Previously she was on the faculty of the Stanford University School of Medicine where she served as Director of the Stanford Comprehensive Epilepsy Center. A graduate of Stanford Medical School, she completed residency training in Neurology at the University of Pennsylvania, as well as fellowship training in EEG and epilepsy. Dr.

Lanzman Bryan in Palo Alto, CA, is a leading healthcare provider specializing in pediatric care through various centers such as the Betty Irene Moore Children's Heart Center and the Bass Childhood Cancer Center. They offer a comprehensive range of services, including advanced treatments and innovative technologies for children facing complex health challenges. The institution also emphasizes accessibility and convenience, providing options for virtual visits and second opinions through a partnership with Stanford Medicine Physicians. Their commitment to patient and family support extends to community classes, nutritional programs, and detailed insurance information to help families navigate their healthcare needs effectively. Generated from the website

Dr. Reena Thomas, MD, PhD, is a Clinical Professor in Neuro Oncology at Stanford Medicine leading a translational research team in immune-based therapy for cancer. Holding dual degrees in medicine and molecular immunology, Dr. Thomas has worked for more than two decades to integrate clinical expertise with a deep understanding of cellular immunotherapy mechanisms and burgeoning technologies such as CAR-T (Chimeric Antigen Receptor T lymphocyte) cell therapy. These scientific advancements center foremost on improving outcomes for her patients with central nervous system tumors and all those impacted by neurologic complications of cancer.As a leader in translational research, Dr.